(1 - 30 von 46
)
VerleihungenDeutsches Ärzteblatt
www.aerzteblatt.de
Thomas Dobmeyer, wissenschaftlicher Assistent am Zentrum für Innere Medizin, Medizinische Klinik III des Universitätsklinikums Frankfurt. Der Preisträger ... Thomas Dobmeyer, wissenschaftlicher Assistent am Zentrum für Innere Medizin, Medizinische Klinik III des Universitätsklinikums Frankfurt. Der Preisträger ...
Rödl & Partner berät PharmaLex bei der Fusion mit BioStat ...RWS Verlag
www.rws-verlag.de
— Thomas Dobmeyer, CEO PharmaLex. Über PharmaLex. PharmaLex ist einer der weltweit größten Anbieter von Spezialdienstleistungen für — Thomas Dobmeyer, CEO PharmaLex. Über PharmaLex. PharmaLex ist einer der weltweit größten Anbieter von Spezialdienstleistungen für ...
Vintura joins forces with PharmaLex in joint ventureVintura Consultancy
www.vintura.com
Thomas Dobmeyer, CEO PharmaLex, commented. “Not only do they have significant strategic experience in the life science sector, such as Market Access and ... Thomas Dobmeyer, CEO PharmaLex, commented. “Not only do they have significant strategic experience in the life science sector, such as Market Access and ...
Vintura joins forces with Pharmalex in joint ventureConsulting Point
www.consultingpoint.com
— Thomas Dobmeyer, CEO PharmaLex, commented. “Not only do they have significant strategic experience in the life science sector, such as — Thomas Dobmeyer, CEO PharmaLex, commented. “Not only do they have significant strategic experience in the life science sector, such as ...
Healthcare must learn from experience to combat global ...Laboratory News
www.labnews.co.uk
— ... Thomas Dobmeyer. Patients are being put at terrible risk from the war in Ukraine. Not only have hospitals and other health facilities been — ... Thomas Dobmeyer. Patients are being put at terrible risk from the war in Ukraine. Not only have hospitals and other health facilities been ...
PharmaLex Gruppe eröffnet Standort in MünchenBionity
www.bionity.com
— Thomas Dobmeyer. Auch Geschäftsführer Dr. Tilo Netzer äußerte sich zustimmend: „Damit können wir jetzt auch hier, Kunden schnell und einfach — Thomas Dobmeyer. Auch Geschäftsführer Dr. Tilo Netzer äußerte sich zustimmend: „Damit können wir jetzt auch hier, Kunden schnell und einfach ...
PharmaLex Strengthens Global Reach and Local Support with ...asianetnews.net
asianetnews.net
— Thomas Dobmeyer. “Onboarding the China team to the PharmaLex Organization underscores our commitment to employing the right expertise in all — Thomas Dobmeyer. “Onboarding the China team to the PharmaLex Organization underscores our commitment to employing the right expertise in all ...
PharmaLex forms joint venture with consulting firm VinturaConsultancy.eu
www.consultancy.eu
— According to Thomas Dobmeyer, CEO of PharmaLex, the firm's broad portfolio enables it to provide its clients with an end-to-end offering — According to Thomas Dobmeyer, CEO of PharmaLex, the firm's broad portfolio enables it to provide its clients with an end-to-end offering.
PharmaLex seals merger with UK's NeoHealthHubPharmaTimes
pharmatimes.com
— ... Thomas Dobmeyer. “By combining our expertise, we are better able to support our clients globally with their market access, data and — ... Thomas Dobmeyer. “By combining our expertise, we are better able to support our clients globally with their market access, data and ...
PharmaLex strengthens foothold in regulatory services ...BlueReg Group
blue-reg.com
— Thomas Dobmeyer. “Both BlueReg and PharmaLex hold similar values with regards to an open, transparent culture and a commitment to serving — Thomas Dobmeyer. “Both BlueReg and PharmaLex hold similar values with regards to an open, transparent culture and a commitment to serving ... Bewertung: 4,8 · 136 Ergebnisse Rezensionen werden von der Google Suche nicht überprüft
Rödl & Partner / Penningtons Manches: Yes übernimmt...
www.lto.de
Die Yes Pharma, eine Portfoliogesellschaft des Finanzinvestors Auctus, hat den britischen Pharma-Dienstleister Wainwright übernommen. Ein internationales...
PharmaLex und YES Pharma Services fusionieren
www.finanznachrichten.de
... zusätzliches Innovationspotential für unsere Kunden beispielsweise im Bereich der Prozessoptimierung." ergänzt Dr. Thomas Dobmeyer, ...
20 Jahre YES: Wachstum und Internationalisierung fest im Blick —...
www.pharma-relations.de
In einer Doppelspitze gemeinsam mit Dr. Thomas Dobmeyer als zweitem Geschäftsführenden Gesellschafter führt er ein nach eigenen Angaben "rundum …
20-jähriges Jubiläum von YES: Wachstum und Internationalisierung...
www.healthreminder.de
Seit führt Dr. Zimmer die Geschäfte gemeinsam mit Dr. Thomas Dobmeyer. YES, mit Hauptsitz in Friedrichsdorf bei Frankfurt am Main, ...
Australian medtech consultancy merges with international leaderbiotechdispatch.com.au › news › australian-medtech...
biotechdispatch.com.au
· PharmaLex CEO Dr Thomas Dobmeyer said the merger would strengthen the company's presence in Australia and New Zealand, as well as the Asia ...
Events - Kempten Business School - Englishwww.hs-kempten-business-school.com › events-en
www.hs-kempten-business-school.com
Dr. Thomas Dobmeyer. CEO and Managing Partner PharmaLex. 29 MARCH PM (CET). Ticket. Nan Fang. Founder & CEO of Singleron Ph.D Immunology. Event DATE
AUCTUS and PharmaLex acquire US Add-Ons - private-equitynews.com
www.private-equitynews.com
... us a partner of choice for global medical device and combination product projects”, explained Dr. Thomas Dobmeyer, CEO PharmaLex.
PharmaLex und YES Pharma Services fusionieren | CHEManager
www.chemanager-online.com
PharmaLex und YES Pharma Services fusionieren. Die neue Unternehmensgruppe mit rund 400 Mitarbeitern, weltweit 12 Standorten und einem jährlichen Umsatz von...
News & Events - Ascent Development Serviceswww.ascent-dev.com › news-events
www.ascent-dev.com
... and scientific affairs services across clinical and regulatory in markets throughout East and Southeast Asia,” said PharmaLex CEO Dr. Thomas Dobmeyer.
With its Ascent Development Services merger, PharmaLex extends ...www.pharmaindustrial-india.com › news › with-its-a...
www.pharmaindustrial-india.com
· ... affairs services across clinical and regulatory in markets throughout East and Southeast Asia,” said PharmaLex CEO Dr. Thomas Dobmeyer.
BioMotiv & PharmaLex Establish Preferred Partnershipwww.biomotiv.com › news-posts › › bi...
www.biomotiv.com
· ... single consistent process and tailored approach for BioMotiv across all of their portfolios”, added Dr. Thomas Dobmeyer, CEO, PharmaLex.
PharmaLex enters into strategic partnership with Volv Global | Drug...
www.drugdiscoverynews.com
New collaboration will use innovative AI technology to support PharmaLex’s pharmacovigilance solutions
CompliMed merges with PharmaLex - Pf Mediapf-media.co.uk › news › complimed-merges-with-p...
pf-media.co.uk
· “CompliMed are a perfect fit for PharmaLex” explained Dr Thomas Dobmeyer, Chief Executive Officer of PharmaLex. “Our strategy is to build a ...
Lutterworth pharma firm merges with major global playerwww.thebusinessdesk.com › Home › News
www.thebusinessdesk.com
· Thomas Dobmeyer, CEO of Pharmalex, added: “The merger with NHH is a welcome step for both our businesses and we are delighted to welcome the ...
Pharma services expert PharmaLex extends reach in Asia with mergerwww.cleanroomtechnology.com › ... › Regulatory
www.cleanroomtechnology.com
· ... affairs services across clinical and regulatory in markets throughout East and Southeast Asia,” said PharmaLex CEO Dr Thomas Dobmeyer.
PharmaLex Adds Pharmacovigilance To Service Portfolio in USwww.technologynetworks.com › ... › News
www.technologynetworks.com
· Thomas Dobmeyer, CEO PharmaLex. “Wenda's vast experience and expertise will allow us to expand our existing offer for our US clients, enabling ...
PharmaLex Group acquires The Degge Group - bionity.comwww.bionity.com › news › pharmalex-group-acquir...
www.bionity.com
· Thomas Dobmeyer, CEO PharmaLex, added, “In the present era of large-scale global investigations and safety issues, The Degge Group enhances the ...
PharmaLex Increases Nordic Presence with DRA Consulting Mergerwww.pharmoutsourcing.com › News ›
www.pharmoutsourcing.com
· Thomas Dobmeyer. “The merger builds on our long relationship with the owners of DRA as both PharmaLex Nordics and DRA Consulting have been part ...
PharmaLex strikes up AI collaboration with Volv - PMLiVE
www.pmlive.com
Dr Thomas Dobmeyer, chief executive officer of PharmaLex, said: “The increasing volume of relevant literature in the medico-scientific domain ...
PharmaLex and Phlexglobal announce mergerwww.manufacturingchemist.com › ... › Directory
www.manufacturingchemist.com
· ... as well as their state-of-the-art regulatory operations and automation technologies,” said PharmaLex CEO Dr Thomas Dobmeyer.
sortiert nach Relevanz / Datum